Free Trial

Matthew Taylor Analyst Performance

Analyst at Jefferies Financial Group

Matthew Taylor is a stock analyst at Jefferies Financial Group, covering 14 publicly traded companies across a range of sectors. Over the past year, Matthew Taylor has issued 4 stock ratings, including buy and hold recommendations. While full access to Matthew Taylor's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Matthew Taylor's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
49 Last 10 Years
Buy Recommendations
55.10% 27 Buy Ratings
Companies Covered
14 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy55.1%26 ratings
Hold40.8%20 ratings
Sell4.1%1 ratings

Out of 49 total stock ratings issued by Matthew Taylor at Jefferies Financial Group, the majority (55.1%) have been Buy recommendations, followed by 40.8% Hold and 4.1% Sell.

Exchange Coverage

ExchangePercentageCount
NYSE
64.3% of companies on NYSE
9 companies
NASDAQ
35.7% of companies on NASDAQ
5 companies

Matthew Taylor, an analyst at Jefferies Financial Group, currently covers 14 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
12 companies
85.7%
Miscellaneous
2 companies
14.3%

Matthew Taylor of Jefferies Financial Group specializes in stock coverage within the Medical sector, with additional focus on companies.

Coverage Industries

IndustryPercentage
MED PRODUCTS
6 companies
42.9%
MED INSTRUMENTS
3 companies
21.4%
MEDICAL DEVICES
2 companies
14.3%
Miscellaneous
2 companies
14.3%
SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES
1 company
7.1%

Matthew Taylor's Ratings History at Jefferies Financial Group

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Shoulder Innovations, Inc. stock logo
SI
Shoulder Innovations
8/25/2025Initiated Coverage$12.63$19.00Buy
Abbott Laboratories stock logo
ABT
Abbott Laboratories
7/18/2025Upgrade$120.76$145.00Buy
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4/17/2025Boost Price Target$129.74$137.00Hold
InMode Ltd. stock logo
INMD
InMode
4/14/2025Lower Price Target$15.05$15.00Hold